This guidance describes the technical standards associated with preparation of the electronic submission template for PMAs/PMA supplements that enable submission of the Designated Application Types solely in electronic format.
This does not include PMA Modules and Modular Shells.
This guidance discusses the information and guided prompts in the electronic submission template that FDA believes will best facilitate the collection and assembly of the necessary
elements of a ‘complete’ submission

